07:31 AM EDT, 09/17/2024 (MT Newswires) -- AC Immune SA ( ACIU ) said Tuesday that it will receive a second milestone payment of 24.6 million Swiss francs ($29.1 million) under its agreement with Johnson & Johnson ( JNJ ) subsidiary Janssen Pharmaceuticals.

The milestone payment follows the rapid rate of prescreening in a trial of JNJ-2056 to treat preclinical Alzheimer's disease, AC Immune ( ACIU ) said.

Shares of AC Immune ( ACIU ) were up about 8% in Tuesday's premarket activity.

Price: 3.5300, Change: +0.26, Percent Change: +7.95